Immunization with Chaperone-Peptide Complex Induces Low-Avidity Cytotoxic T Lymphocytes Providing Transient Protection against Herpes Simplex Virus Infection
Open Access
- 1 January 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 76 (1) , 136-141
- https://doi.org/10.1128/jvi.76.1.136-141.2002
Abstract
Heat shock proteins loaded with viral peptides were shown to induce a CD8 + T cell response and confer protective immunity against challenge with herpes simplex virus (HSV). The delivery system consisted of recombinant human hsp70 coupled to the peptide SSIEFARL, which is the immunodominant peptide epitope, recognized by HSV specific T cells in C57BL/6 mice. Immunization resulted in CD8 + T-cell responses, measured by peptide-specific tetramers and peptide-induced intracellular gamma interferon expression and cytotoxicity, similar to responses resulting from immunization with a recombinant vaccinia virus that expressed SSIEFARL as a minigene (VvgB) and UV-inactivated HSV. However, the durability of the hsp70-SSIEFARL response was less than that resulting from VvgB and HSV immunization and in addition the CD8 + T-cell responses in the memory phase were functionally less effective. Mice challenged soon after immunization showed excellent immunity, but by 90 days postimmunization this had waned to be significantly less than the level of immunity in both VvgB- and HSV-immunized mice.Keywords
This publication has 28 references indexed in Scilit:
- Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer stainingInternational Immunology, 2001
- Lymphotoxin α−/− Mice Develop Functionally Impaired CD8+ T Cell Responses and Fail to Contain Virus Infection of the Central Nervous SystemThe Journal of Immunology, 2001
- Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70Proceedings of the National Academy of Sciences, 2000
- Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70Proceedings of the National Academy of Sciences, 2000
- Immunization with a Lymphocytic Choriomeningitis Virus Peptide Mixed with Heat Shock Protein 70 Results in Protective Antiviral Immunity and Specific Cytotoxic T LymphocytesThe Journal of Experimental Medicine, 1998
- Synthetic peptides non‐covalently bound to bacterial hsp 70 elicit peptide‐specific T‐cell responses in vivoImmunology, 1996
- A Mechanism for the Specific Immunogenicity of Heat Shock Protein-Chaperoned PeptidesScience, 1995
- Vaccine technologies: view to the futureScience, 1994
- Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo.Proceedings of the National Academy of Sciences, 1994
- Heat shock protein 70-associated peptides elicit specific cancer immunity.The Journal of Experimental Medicine, 1993